Endorphin Engine MG-7
Your body's own pharmacy, perfected
Overview
The Endorphin Engine MG-7 represents a revolutionary approach to pain management and mood optimization. This implantable bioreactor synthesizes pharmaceutical-grade endorphins and related compounds directly within your body, eliminating the need for external medication while providing precisely controlled relief on demand. Originally developed for military and medical applications requiring sustained pain management without cognitive impairment, the MG-7 is now available for qualified civilian candidates seeking freedom from chronic pain or enhanced emotional regulation.
Key Features
On-Demand Synthesis
Produces pharmaceutical-grade endogenous opioids in response to pain signals or user activation.
Precision Dosing
AI-controlled release system prevents overdose while ensuring optimal therapeutic effect.
Tolerance Management
Proprietary cycling protocol minimizes tolerance development and dependence.
Mood Stabilization
Optional serotonin and dopamine co-production for comprehensive emotional wellness.
Emergency Override
Maximum output mode for trauma situations - use with medical supervision.
Freedom From Pain
The Endorphin Engine MG-7 liberates you from the cycle of prescriptions, pharmacy visits, and the stigma of pain medication. Your body becomes its own perfectly calibrated pharmaceutical production facility.
How It Works
The MG-7 contains a bioengineered cell culture derived from your own stem cells, programmed to produce natural opioid peptides. These compounds are chemically identical to your body’s own endorphins but produced in therapeutic quantities.
Production Modes
- Baseline: Low-level continuous production for chronic pain management
- Active: Enhanced output triggered by detected pain signals
- Manual: User-activated boost via neural interface or app
- Emergency: Maximum production for acute trauma (time-limited, monitored)
- Wellness: Optional mood enhancement compounds for emotional balance
Safety Systems
Multiple redundant safety systems prevent misuse:
- Real-time blood concentration monitoring
- Automatic production limits based on individual tolerance
- Mandatory rest periods between high-output sessions
- Remote physician override capability
- Emergency naloxone co-production if critical thresholds exceeded
Subscription Model
The MG-7 Comfort Plan includes:
- Device implantation and calibration
- Monthly remote monitoring and optimization
- Annual in-person checkups
- Firmware updates and feature additions
- 24/7 emergency support line
Starting at €450/month after initial device cost
Candidate Screening
Due to the nature of this product, all candidates undergo comprehensive psychological and medical screening. Approval typically takes 2-4 weeks. Accelerated screening available at UPG Zeta walk-in center.
Pain is optional. Choose comfort.
Contraindications
- History of substance use disorder (enhanced monitoring required)
- Concurrent use of external opioid medications
- Individuals with addictive personalities - careful screening required
- Those seeking the device purely for recreational purposes
- Pregnancy or planned pregnancy